On March 16, 2010
Biotech OSI Gathers All-Star Defense to Stiff-Arm a Hostile Takeover Bid
OSI Pharmaceuticals (OSIP) rejected the $3.5 billion hostile takeover launched by Astellas Pharma, and the biotech is assembling an all-star defense as it prepares for battle.
No tags for this post.
0 Comments